Assembly Biosciences (ASMB) Payables (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Payables of $1.1 million for Q1 2026, up 29.03% year-over-year from $875000.0 in Q1 2025, and down 3.59% quarter-over-quarter from $1.2 million in Q4 2025.
Assembly Biosciences (ASMB) Payables (2010 - 2026) Analysis & Trends
Assembly Biosciences' Payables history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Payables rose 29.03% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 29.03% YoY), while the FY2025 annual figure was $1.2 million, up 100.17% from the prior year.
- Payables for Q1 2026 stood at $1.1 million, down from $1.2 million in the prior quarter.
- The five-year high for Payables was $2.5 million in Q4 2022, with the low at $461000.0 in Q4 2023.
- The 5-year median for Payables is $1.1 million (2026), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2025: Payables plunged 81.51% in 2023, then soared 100.17% in 2025.
- Assembly Biosciences' Payables stood at $2.5 million in 2022, then plunged by 81.51% to $461000.0 in 2023, then advanced by 26.9% to $585000.0 in 2024, then jumped by 100.17% to $1.2 million in 2025, then fell by 3.59% to $1.1 million in 2026.
- Business Quant data shows ASMB's Payables at $1.1 million in Q1 2026, $1.2 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 743,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Dec 31, 2024 | 585,000.00 |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 801,000.00 |
| Mar 31, 2024 | 727,000.00 |
| Dec 31, 2023 | 461,000.00 |
| Sep 30, 2023 | 758,000.00 |
| Jun 30, 2023 | 904,000.00 |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | 2.49 Mn |
| Sep 30, 2022 | 1.94 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 1.41 Mn |
| Dec 31, 2021 | 2.66 Mn |
| Sep 30, 2021 | 2.63 Mn |